Zoetis Profile

Performance

   

Odds of Distress

11%11%
Fiscal Quarter End: December 31, 2019
Equity ratings for Zoetis are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting August 23, 2019 and ending today November 21, 2019. Click here to learn more.

Zoetis Profile

Next fiscal quarter end is expected on December 31, 2019. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drugs - Generic classification in USA and is traded on BATS Exchange. It employs 10000 people. more
NameZoetis
CEOJuan AlaixView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address10 Sylvan Way, Parsippany, NJ 07054, United States
ExchangeBATS Exchange
CIK Number0001555280
ISINUS98978V1035
SectorHealthcare
IndustryDrugs - Generic
BenchmarkDOW
Websitewww.zoetis.com
Phone973 822 7000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestOctober 31, 2019
Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 56.58 B. Zoetis runs under Healthcare sector within Drugs - Generic industry. The entity has 476.3 M outstanding shares of which 3.67 M shares are at this time shorted by investors with about 1.99 days to cover shorted positions. has about 1.84 B in cash with 1.08 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.86.
Check Zoetis Probability Of Bankruptcy

Ownership Allocation (%)

Zoetis Target Price Odds Analysis

Odds Below 120.22HorizonTargetOdds Above 120.22
13.86%30 days 120.22 85.92%
Based on normal probability distribution, the odds of Zoetis to move above current price in 30 days from now is about 85.92 (This Zoetis probability density function shows the probability of Zoetis Stock to fall within a particular range of prices over 30 days) .

Zoetis Top Holders

Zoetis Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares38.7 M4.8 B
Vanguard Group IncCommon Shares37.1 M4.6 B
View Zoetis Diagnostics

Zoetis Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Zoetis Key Fundamentals

Zoetis Against Markets

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Zoetis Upcoming and Recent Events

Zoetis Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 13, 2020
Next Earnings ReportMay 7, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 13, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Zoetis Corporate Filings

Zoetis SEC Reporting

Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Other Events
Submission of Matters to a Vote of Security Holders

Zoetis Distributions to stockholders

Zoetis Corporate Directors

William Steere Independent Director
Linda Rhodes Independent Director
Frank DAmelio Independent Director
See also Your Current Watchlist. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.
Search macroaxis.com